Scientists identify key kala-azar proteinApril 27th, 2008 - 12:54 pm ICT by admin
By Sanjit Bagchi
New Delhi, April 27 (IANS) Indian researchers have identified a key protein that plays an important role in regulating the survival, infectivity and drug response of the parasite that causes visceral leishmaniasis - better known as ‘kala-azar’. Kala-azar is the most severe form of leishmaniasis, and is caused by a parasite called Leishmania donovani, which spreads to people through the bite of an infected female sandfly, Scidev.Net reported.
Jitesh P. Iyer and co-workers from the National Institute of Immunology, found that higher levels of an enzyme called cTXNPx made the L. donovani parasite more virulent at certain times in its life cycle. Laboratory tests also showed a higher parasite burden in immune cells.
cTXNPx belongs to the group of enzymes that detoxify peroxides, chemicals that are toxic to L. donovani. When humans are infected by L. donovani, their immune cells release hydrogen peroxide to destroy the parasite.
Parasites with higher levels of cTXNPx were more able to withstand high levels of hydrogren peroxide, and were also resistant to an antileishmanial drug.
“This study provides a link between cTXNPx expression to survival, virulence and drug response in L. donovani,” the researchers write in a paper published in the April issue of the journal Molecular Microbiology.
“This study invites further studies to explore the plausibility of any new drug molecule targeting this enzyme,” said Swapan Jana of the Society for Social Pharmacology.
“The study is impressive - given the emerging drug resistance of Leishmania donovani, it’s important to work on the ways to combat the parasite through newer drugs.”
Drug-resistance of L. donovani is a major issue in developing countries like India, said Jana.
“Even though different centres have reported different findings, it is a fact that resistance [of L. donovani] to the first line drug sodium antimony gluconate has been increasing since the late 1970s,” said Sarman Singh of the All India Institute of Medical Sciences.
Kala-azar is endemic in four Indian states, the worst affected being Bihar. The disease infects about 300,000 people and kills 20,000 in India each year.
“In some areas of Bihar, drug resistance is reported in up to 70 percent of cases,” added Singh.
- Indian scientists find safe drug against kala azar - Sep 10, 2012
- Kala-azar outbreak in West Bengal district - Jun 13, 2010
- First vaccine against kala azar ready for trial - Feb 22, 2012
- Kala Azar affects 252 people in West Bengal district - Jul 28, 2010
- MSF battles kala azar in Bihar - Jul 17, 2012
- Cancer drugs may help battle parasite Leishmania - Jul 17, 2010
- Kala azar now part of Bihar school text book - Aug 02, 2011
- Arthritis drug found effective in amoebic dysentery - May 21, 2012
- HIV drugs can also kill malaria parasites: Study - May 03, 2011
- Modified bone drug kills malaria parasite - Feb 28, 2012
- Communicable diseases a major health challenge: Minister - Dec 21, 2011
- Bihar hikes financial help for kala azar patients - Apr 24, 2012
- After polio, Bihar targets kala azar - Jan 30, 2012
- Leishmania parasites undergo sexual reproduction in sand flies - Apr 10, 2009
- Bihar to involve youths to fight kala azar - Apr 10, 2012
Tags: bagchi, drug molecule, drug resistance, drug response, gluconate, group of enzymes, hydrogen peroxide, immune cells, indian researchers, infectivity, iyer, kala azar, molecular microbiology, national institute of immunology, plausibility, release hydrogen, sanjit, social pharmacology, swapan, virulence